China Resources Boya Bio-pharmaceutical Group Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001FF1
CNY
22.45
0.1 (0.45%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
466.15
471.90
535.88
489.80
349.37
447.28
444.44
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
466.15
471.90
535.88
489.80
349.37
447.28
444.44
Raw Material Cost
201.42
246.58
268.13
214.59
136.11
163.33
156.89
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.21
0.36
0.09
0.54
0.02
0.09
0.02
Selling and Distribution Expenses
207.28
141.31
138.05
194.00
109.93
124.15
132.28
Other Expenses
1.35
1.11
0.94
1.78
1.59
1.02
1.80
Total Expenditure (Excl Depreciation)
422.37
399.39
415.63
426.98
261.96
297.77
307.14
Operating Profit (PBDIT) excl Other Income
43.8
72.5
120.19999999999999
62.800000000000004
87.4
149.5
137.3
Other Income
27.69
20.67
23.94
20.22
7.57
26.44
19.82
Operating Profit (PBDIT)
66.69
130.58
181.06
25.39
123.19
197.22
183.91
Interest
0.21
0.36
0.09
0.54
0.02
0.09
0.02
Exceptional Items
11.37
12.27
24.74
4.77
21.73
20.57
18.52
Gross Profit (PBDT)
264.73
225.32
267.75
275.20
213.26
283.95
287.55
Depreciation
0.00
42.35
42.35
32.32
32.32
26.13
26.13
Profit Before Tax
77.85
100.13
163.35
-2.71
112.58
191.58
176.27
Tax
-39.78
14.02
24.06
13.19
15.85
27.63
24.51
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
117.62
85.86
139.48
-15.71
96.73
163.95
152.02
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
117.62
85.86
139.48
-15.71
96.73
163.95
152.02
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.01
0.26
-0.19
-0.19
-0.00
-0.00
-0.26
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
117.63
86.12
139.29
-15.90
96.73
163.94
151.76
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
7,670.76
7,628.47
7,626.26
7,487.15
7,581.18
7,484.45
7,471.78
Earnings per share (EPS)
0.23
0.17
0.28
-0.03
0.19
0.33
0.3
Diluted Earnings per share
0.23
0.17
0.28
-0.03
0.19
0.33
0.3
Operating Profit Margin (Excl OI)
8.37%
14.32%
21.42%
-5.54%
23.84%
32.34%
31.04%
Gross Profit Margin
16.7%
30.19%
38.39%
6.05%
41.47%
48.67%
45.54%
PAT Margin
25.23%
18.19%
26.03%
-3.21%
27.69%
36.65%
34.21%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is -1.21% vs -11.94% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 36.59% vs -38.19% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -64.51% vs -30.04% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is -50.00% vs 300.00% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of China Resources Boya Bio-pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
466.15
0
466.15
Other Operating Income
0.00
0.00
0.00
Total Operating income
466.15
0
466.15
Raw Material Cost
201.42
0
201.42
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.21
0
0.21
Selling and Distribution Expenses
207.28
0
207.28
Other Expenses
1.35
0.00
1.35
Total Expenditure (Excl Depreciation)
422.37
0
422.37
Operating Profit (PBDIT) excl Other Income
43.78
0.00
43.78
Other Income
27.69
0
27.69
Operating Profit (PBDIT)
66.69
0
66.69
Interest
0.21
0
0.21
Exceptional Items
11.37
0
11.37
Gross Profit (PBDT)
264.73
0
264.73
Depreciation
0.00
0
0.00
Profit Before Tax
77.85
0
77.85
Tax
-39.78
0
-39.78
Provisions and contingencies
0
0
0.00
Profit After Tax
117.62
0
117.62
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
117.62
0
117.62
Share in Profit of Associates
0
0
0.00
Minority Interest
0.01
0
0.01
Other related items
0.00
0.00
0.00
Consolidated Net Profit
117.63
0
117.63
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
7,670.76
0
7,670.76
Earnings per share (EPS)
0.23
0
0.23
Diluted Earnings per share
0.23
0
0.23
Operating Profit Margin (Excl OI)
8.37%
0%
0.00
8.37%
Gross Profit Margin
16.70%
0%
0.00
16.70%
PAT Margin
25.23%
0%
0.00
25.23%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 46.62 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -1.21% vs -11.94% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 33.43% vs -46.20% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 11.76 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 36.59% vs -38.19% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 21.61% vs -31.66% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.90 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -64.51% vs -30.04% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -66.26% vs -22.78% in Sep 2024

Quarterly - Interest
Interest 0.02 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -50.00% vs 300.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.37%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024